Home/Investors/Undisclosed

Undisclosed

Biotech Investor · 11 portfolio companies

Portfolio

11

Focus Areas

15

Top Stage

preclinical

Investment Focus

Neurodegenerative Diseases Oncology Immunology Neurological Disorders Psychiatric Disorders Gastrointestinal Diseases Metabolic Disorders Idiopathic Pulmonary Fibrosis Fibrotic Diseases Cardiovascular Diseases Age-Related Diseases Infectious Diseases Age-related Diseases Gastrointestinal Neuroscience

Portfolio Companies

Company	Stage	Valuation	Focus
Modulo Bio	Pre-clinical	—	Neurodegenerative Diseases
BioHeal AI	platform	—	Oncology, Immunology
Holobiome	Pre-clinical	—	Neurological Disorders, Psychiatric Disorders
Refoxy Pharmaceuticals	Pre-clinical	—	Idiopathic Pulmonary Fibrosis, Fibrotic Diseases
Inso Biosciences	—	—	—
Scope Biosciences	Commercial	—	—
Living Models	platform	—	Oncology, Infectious Diseases
Metanovas Biotech	preclinical	—	Metabolic Disorders, Age-related Diseases
iCamumo	preclinical	—	Metabolic Disorders, Gastrointestinal
Switchpoint Bio	preclinical	—	Oncology
Spinogenix	preclinical	—	Neuroscience, Neurodegenerative Diseases